• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

衡量健康领域在银屑病中的重要性——离散选择实验与评分量表的比较

Measuring the importance of health domains in psoriasis - discrete choice experiment versus rating scales.

作者信息

Gutknecht Mandy, Schaarschmidt Marthe-Lisa, Danner Marion, Blome Christine, Augustin Matthias

机构信息

German Center for Health Services Research in Dermatology (CVderm), Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.

Department of Dermatology, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.

出版信息

Patient Prefer Adherence. 2018 Mar 15;12:363-373. doi: 10.2147/PPA.S152509. eCollection 2018.

DOI:10.2147/PPA.S152509
PMID:29588575
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5858654/
Abstract

BACKGROUND

Psoriasis affects different aspects of health-related quality of life (eg, physical, psychological, and social impairments); these health domains can be of different importance for patients. The importance of domains can be measured with the Patient Benefit Index (PBI). This questionnaire weights the achievement of treatment goals by Likert scales (0, "not important at all" to 4, "very important") using the Patient Needs Questionnaire (PNQ). Treatment goals assessed with the PBI have been assigned to five health domains; the importance of each domain can be calculated as the average importance of the respective treatment goals. In this study, the PBI approach of deriving importance weights is contrasted to a discrete choice experiment (DCE), in order to determine the importance of health domains in psoriasis, and to find if the resulting weights will differ when derived from these two methods.

METHODS

Adult patients with psoriasis completed both questionnaires (PNQ, DCE). The PBI domains were used as attributes in the DCE with the levels "did not help at all", "helped moderately", and "helped a lot".

RESULTS

Using DCE, "improving physical functioning" was the most important health domain, followed by "improving psychological well-being". Using PNQ, these domains were ranked in position two and three following "strengthening confidence in the therapy and in a possible healing". The latter was least important using DCE. The only agreement of ranking was shown in "reducing impairments due to therapy" (position four). "Improving social functioning" was ranked in position three (DCE) and five (PNQ).

CONCLUSION

Health domains have different importance to patients with psoriasis. Using PNQ or DCE to determine the importance of domains results in markedly different rankings; both approaches can thus not be considered equivalent. However, in this study, importance was assessed at the domain level in DCE and at the single item level in PNQ, which may have added to the differences.

摘要

背景

银屑病会影响健康相关生活质量的不同方面(如身体、心理和社会功能损害);这些健康领域对患者的重要性可能各不相同。领域的重要性可用患者获益指数(PBI)来衡量。该问卷使用患者需求问卷(PNQ),通过李克特量表(0表示“完全不重要”至4表示“非常重要”)对治疗目标的达成情况进行加权。用PBI评估的治疗目标已被归入五个健康领域;每个领域的重要性可通过相应治疗目标的平均重要性来计算。在本研究中,将PBI得出重要性权重的方法与离散选择实验(DCE)进行对比,以确定银屑病患者健康领域的重要性,并探究从这两种方法得出的权重是否会有所不同。

方法

成年银屑病患者完成了两份问卷(PNQ、DCE)。PBI领域被用作DCE中的属性,其水平为“完全没有帮助”“有一定帮助”和“帮助很大”。

结果

使用DCE时,“改善身体功能”是最重要的健康领域,其次是“改善心理健康”。使用PNQ时,这两个领域在“增强对治疗及可能治愈的信心”之后分别排在第二和第三位。后者在DCE中是最不重要的。唯一排名一致的是“减少治疗引起的损害”(第四位)。“改善社会功能”在DCE中排名第三,在PNQ中排名第五。

结论

健康领域对银屑病患者具有不同的重要性。使用PNQ或DCE来确定领域的重要性会得出明显不同的排名;因此不能认为这两种方法是等效的。然而,在本研究中,DCE是在领域层面评估重要性,而PNQ是在单个项目层面评估,这可能加剧了差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bafc/5858654/0aa8b46e246a/ppa-12-363Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bafc/5858654/e2da5df23a2d/ppa-12-363Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bafc/5858654/86cbb6970f1f/ppa-12-363Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bafc/5858654/ea6bf5edbd20/ppa-12-363Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bafc/5858654/0aa8b46e246a/ppa-12-363Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bafc/5858654/e2da5df23a2d/ppa-12-363Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bafc/5858654/86cbb6970f1f/ppa-12-363Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bafc/5858654/ea6bf5edbd20/ppa-12-363Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bafc/5858654/0aa8b46e246a/ppa-12-363Fig4.jpg

相似文献

1
Measuring the importance of health domains in psoriasis - discrete choice experiment versus rating scales.衡量健康领域在银屑病中的重要性——离散选择实验与评分量表的比较
Patient Prefer Adherence. 2018 Mar 15;12:363-373. doi: 10.2147/PPA.S152509. eCollection 2018.
2
How to weight patient-relevant treatment goals for assessing treatment benefit in psoriasis: preference elicitation methods vs. rating scales.如何权衡与患者相关的治疗目标,以评估银屑病的治疗获益:偏好 elicitation 方法与评分量表。
Arch Dermatol Res. 2018 Sep;310(7):567-577. doi: 10.1007/s00403-018-1846-4. Epub 2018 Jun 23.
3
Assessing the Importance of Treatment Goals in Patients with Psoriasis: Analytic Hierarchy Process vs. Likert Scales.评估银屑病患者治疗目标的重要性:层次分析法与李克特量表。
Patient. 2018 Aug;11(4):425-437. doi: 10.1007/s40271-018-0300-1.
4
Comparing Discrete Choice Experiment with Swing Weighting to Estimate Attribute Relative Importance: A Case Study in Lung Cancer Patient Preferences.比较离散选择实验和挥重法估计属性相对重要性:肺癌患者偏好的案例研究。
Med Decis Making. 2024 Feb;44(2):203-216. doi: 10.1177/0272989X231222421. Epub 2024 Jan 4.
5
Treatment Goals for Psoriasis as Measured by Patient Benefit Index: Results of a National Psoriasis Foundation Survey.患者获益指数衡量的银屑病治疗目标:一项全国银屑病基金会调查结果。
Adv Ther. 2022 Jun;39(6):2657-2667. doi: 10.1007/s12325-022-02124-2. Epub 2022 Apr 11.
6
Unmet Personal Patient Needs in Psoriasis Patients with Low Disease Activity on Adalimumab, Etanercept or Ustekinumab.使用阿达木单抗、依那西普或乌司奴单抗治疗后疾病活动度低的银屑病患者未满足的个人患者需求
Drugs Real World Outcomes. 2021 Jun;8(2):163-172. doi: 10.1007/s40801-021-00227-w. Epub 2021 Mar 28.
7
Validation of the patient benefit index for the assessment of patient-relevant benefit in the treatment of psoriasis.验证患者获益指数在评估银屑病治疗中患者相关获益的应用。
Arch Dermatol Res. 2012 Aug;304(6):433-41. doi: 10.1007/s00403-012-1256-y. Epub 2012 Jun 22.
8
Comparing Analytic Hierarchy Process and Discrete-Choice Experiment to Elicit Patient Preferences for Treatment Characteristics in Age-Related Macular Degeneration.比较层次分析法和离散选择实验以引出年龄相关性黄斑变性患者对治疗特征的偏好。
Value Health. 2017 Sep;20(8):1166-1173. doi: 10.1016/j.jval.2017.04.022. Epub 2017 May 31.
9
Analysis of physicians' perspectives versus patients' preferences: direct assessment and discrete choice experiments in the therapy of multiple myeloma.分析医生观点与患者偏好:多发性骨髓瘤治疗中的直接评估和离散选择实验。
Eur J Health Econ. 2011 Jun;12(3):193-203. doi: 10.1007/s10198-010-0218-6. Epub 2010 Jan 28.
10
Discrete-choice experiments versus rating scale exercises to evaluate the importance of attributes.离散选择实验与评级量表练习以评估属性的重要性。
Expert Rev Pharmacoecon Outcomes Res. 2015;15(4):721-8. doi: 10.1586/14737167.2015.1033406. Epub 2015 Apr 3.

引用本文的文献

1
The Evolving Landscape of Discrete Choice Experiments in Health Economics: A Systematic Review.健康经济学中离散选择实验的发展态势:一项系统综述
Pharmacoeconomics. 2025 May 21. doi: 10.1007/s40273-025-01495-y.

本文引用的文献

1
Evaluation of psoriasis patients' attitudes toward benefit-risk and therapeutic trade-offs in their choice of treatments.评估银屑病患者在选择治疗方法时对获益-风险及治疗权衡的态度。
Patient Prefer Adherence. 2017 Feb 28;11:353-362. doi: 10.2147/PPA.S121838. eCollection 2017.
2
A systematic review on methods used to evaluate patient preferences in psoriasis treatments.一项关于评估银屑病治疗中患者偏好所使用方法的系统评价。
J Eur Acad Dermatol Venereol. 2016 Sep;30(9):1454-64. doi: 10.1111/jdv.13749. Epub 2016 Jul 19.
3
Comparing preferences for outcomes of psoriasis treatments among patients and dermatologists in the U.K.: results from a discrete-choice experiment.
比较英国患者和皮肤科医生对银屑病治疗结果的偏好:一项离散选择实验的结果。
Br J Dermatol. 2017 Mar;176(3):777-785. doi: 10.1111/bjd.14798. Epub 2016 Sep 24.
4
Patient-relevant treatment goals in psoriasis.银屑病中与患者相关的治疗目标。
Arch Dermatol Res. 2016 Mar;308(2):69-78. doi: 10.1007/s00403-015-1613-8. Epub 2015 Dec 19.
5
European S3-Guidelines on the systemic treatment of psoriasis vulgaris--Update 2015--Short version--EDF in cooperation with EADV and IPC.欧洲寻常型银屑病系统治疗S3指南——2015年更新版——简版——欧洲皮肤病学基金会与欧洲皮肤病与性病学会及国际银屑病理事会合作制定
J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2277-94. doi: 10.1111/jdv.13354. Epub 2015 Oct 19.
6
Patient Preferences for Treatment of Psoriasis with Biologicals: A Discrete Choice Experiment.患者对生物制剂治疗银屑病的偏好:一项离散选择实验。
PLoS One. 2015 Jun 9;10(6):e0129120. doi: 10.1371/journal.pone.0129120. eCollection 2015.
7
Patient preferences for HIV/AIDS therapy - a discrete choice experiment.患者对 HIV/AIDS 疗法的偏好 - 离散选择实验。
Health Econ Rev. 2013 May 11;3(1):14. doi: 10.1186/2191-1991-3-14.
8
Global epidemiology of psoriasis: a systematic review of incidence and prevalence.全球银屑病流行病学:发病率和患病率的系统评价。
J Invest Dermatol. 2013 Feb;133(2):377-85. doi: 10.1038/jid.2012.339. Epub 2012 Sep 27.
9
Things are Looking up Since We Started Listening to Patients: Trends in the Application of Conjoint Analysis in Health 1982-2007.自我们开始倾听患者意见以来,情况有所好转:1982-2007 年联合分析在健康领域的应用趋势。
Patient. 2008 Dec 1;1(4):273-82. doi: 10.2165/01312067-200801040-00009.
10
Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force.联合分析在健康领域的应用——检查表:ISPOR 联合分析实践良好研究报告任务组报告。
Value Health. 2011 Jun;14(4):403-13. doi: 10.1016/j.jval.2010.11.013. Epub 2011 Apr 22.